Sangamo Therapeutics Inc (SGMO)

Apr 03, 2026

Sangamo (NASDAQ: SGMO) awards 225,000 stock options to accounting chief - Stock Titan

Apr 03, 2026

Apr 03, 2026

Sangamo (SGMO) CEO Sandy Macrae receives 2.5M stock option grant at $0.2601 - Stock Titan

Apr 03, 2026

Apr 03, 2026

Sangamo (NASDAQ: SGMO) CLO awarded 800,000 options at $0.2601 - stocktitan.net

Apr 03, 2026

Apr 03, 2026

Equities Analysts Issue Forecasts for SGMO FY2028 Earnings - MarketBeat

Apr 03, 2026

Apr 02, 2026

Sangamo Therapeutics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SGMO) 2026-04-02 - Seeking Alpha

Apr 02, 2026

Apr 02, 2026

SGMO News | SANGAMO THERAPEUTICS INC (NASDAQ:SGMO) - ChartMill

Apr 02, 2026

Apr 01, 2026

Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty - TipRanks

Apr 01, 2026

Mar 31, 2026

RBC Capital Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating, Maintains Target Price $2 - Moomoo

Mar 31, 2026

Mar 31, 2026

Sangamo Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

Sangamo: Q4 Earnings Snapshot - theheraldreview.com

Mar 31, 2026

Mar 31, 2026

Sangamo Reports Pipeline Progress And Wider FY25 Loss, Stock Down 17% Overnight - RTTNews

Mar 31, 2026

Mar 31, 2026

Sangamo Therapeutics (SGMO) Q4 Loss Highlights Deep TTM Deficit Challenging Bullish Profitability Hopes - Sahm

Mar 31, 2026

Mar 31, 2026

Sangamo Therapeutics Q4 2025 Earnings Call Transcript - MarketBeat

Mar 31, 2026

Mar 30, 2026

Sangamo Therapeutics Inc (SGMO) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics Q4 Earnings Call Highlights - marketbeat.com

Mar 30, 2026

Mar 30, 2026

Earnings call transcript: Sangamo’s Q4 2025 earnings miss, stock fluctuates By Investing.com - Investing.com Australia

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 30, 2026

Mar 30, 2026

Sangamo targets summer 2026 for Fabry BLA submission while advancing neurology pipeline and partner talks - MSN

Mar 30, 2026

Mar 30, 2026

SGMO Faces Uncertainty Without Additional Funding - GuruFocus

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - moomoo.com

Mar 30, 2026

Mar 30, 2026

Sangamo (SGMO) Reports Robust Revenue Growth and Pipeline Progre - gurufocus.com

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics (NASDAQ:SGMO) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS - marketbeat.com

Mar 30, 2026

Mar 30, 2026

Earnings call transcript: Sangamo’s Q4 2025 earnings miss, stock fluctuates - Investing.com

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics Q4 Loss Is Unchanged, Revenue Climbs - Moomoo

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics earnings missed by $0.10, revenue fell short of estimates - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

Q4 2025 Sangamo Therapeutics Inc Earnings Call Transcript - GuruFocus

Mar 30, 2026

Mar 30, 2026

BRIEF-Sangamo Therapeutics Q4 EPS USD -0.11 - TradingView

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics, Inc. Reports Unaudited consolidated Impairment Charges for the Fourth Quarter Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Sangamo Therapeutics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnin - Benzinga

Mar 30, 2026

Mar 27, 2026

Sangamo Therapeutics, Inc. Trade Ideas — LSX:936386 - tradingview.com

Mar 27, 2026

Mar 27, 2026

Sangamo Therapeutics Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView

Mar 27, 2026

Mar 25, 2026

Gains Report: Is Sangamo Therapeutics Inc a strong growth stockEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Sangamo Therapeutics Inc (SGMO) - stocktitan.net

Mar 22, 2026

Mar 19, 2026

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call - The Manila Times

Mar 19, 2026

Mar 18, 2026

Sangamo Therapeutics (SGMO) NASDAQ US 18 Mar 2026: Market closed, earnings tonight - Meyka

Mar 18, 2026

Mar 15, 2026

SGMO SEC FilingsSangamo Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 15, 2026

Mar 14, 2026

EPS Watch: Does Sangamo Therapeutics Inc have consistent dividend growth2026 PostEarnings & Real-Time Buy Signal Notifications - baoquankhu1.vn

Mar 14, 2026

Mar 12, 2026

Sangamo seeks accelerated US approval of gene therapy for Fabry - Fabry Disease News

Mar 12, 2026

Mar 11, 2026

Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Sangamo Biosciences (SGMO) and Protalix (PLX) - The Globe and Mail

Mar 11, 2026

Mar 10, 2026

Sangamo Therapeutics (SGMO) shares stabilize amid recent key pipeline update - MSN

Mar 10, 2026

Mar 10, 2026

Fabry Disease Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, AVROBIO, 4D Molecular Therapeutics - Barchart

Mar 10, 2026

Mar 09, 2026

Sangamo (SGMO) Advances FDA Submission for Gene Therapy Approval - GuruFocus

Mar 09, 2026

Mar 09, 2026

Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease - The Manila Times

Mar 09, 2026

Mar 09, 2026

One-time Fabry gene therapy from Sangamo moves toward FDA accelerated approval - Stock Titan

Mar 09, 2026

Mar 09, 2026

Sangamo Therapeutics (SGMO) to Release Earnings on Monday - marketbeat.com

Mar 09, 2026

Mar 07, 2026

SGMO PE Ratio & Valuation, Is SGMO Overvalued - Intellectia AI

Mar 07, 2026

Mar 07, 2026

Day Trade: Is Sangamo Therapeutics Inc. (GBY) stock among top earnings playsTrade Volume Summary & Technical Pattern Alert System - Naître et grandir

Mar 07, 2026

Mar 03, 2026

Risk Report: Does Sangamo Therapeutics Inc have consistent dividend growth - baoquankhu1.vn

Mar 03, 2026

Mar 02, 2026

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Short Interest Update - MarketBeat

Mar 02, 2026